From: From DNA to RNA to disease and back: The 'central dogma' of regulatory disease variation
Gene | Disease | Reference |
---|---|---|
CAT | Hypertension | [12] |
CCR5 | HIV-1 progression and transmission | |
CD209 | Dengue fever | [15] |
CRP | Cardiovascular disease risk | [16] |
CTLA4 | Autoimmune disease | [9] |
DARC | Malaria susceptibility | [10] |
DAT1 | Attention deficit hyperactivity disorder | [17] |
FCRL3 | Rheumatoid arthritis and autoimmune disease | [18] |
GSK3B | Parkinson's disease | [19] |
IGFBP3 | Breast cancer | [20] |
INS | Type I diabetes | [21] |
IPF1 | Type II diabetes | [22] |
MMP-1 | Breast cancer progression | [23] |
MMP-3 | Coronary artery disease | |
NFKB1 | Inflammatory bowel disease | [26] |
RET | Hirschsprung's disease | |
SMYD3 | Colorectal cancer, breast cancer, hepatocellular carcinoma | [11] |
TNF | Malaria | [29] |